EP Patent

EP4349334B1 — Palatable liquid solution containing high concentration of miglustat

Assigned to Theranexus SA · Expires 2025-03-19 · 1y expired

What this patent protects

Patent listed against Micro-K 10.

Drugs covered by this patent

Patent Metadata

Patent number
EP4349334B1
Jurisdiction
EP
Classification
Expires
2025-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Theranexus SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.